Código QR (código de barras bidimensional)

Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia

Gilteritinib treats acute myeloid leukemia (AML) with the FMS-like receptor tyrosine kinase-3 (FLT3) internal tandem duplication (ITD) mutation. Dysregulation of histone modification affects the genesis and progression of AML. Strategies targeting key histone regulators have not been applied to the...

Fuld beskrivelse

Na minha lista:
Principais autores: Qi Zhou, Yongyu Guan, Pingping Zhao, Huiyuan Chu, Yaming Xi
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2025-02-01
Serier:Translational Oncology
Fag:
Acute myeloid leukemia
FLT3-ITD
Gilteritinib
GSK-J4
Combination therapy
Online adgang:http://www.sciencedirect.com/science/article/pii/S1936523325000026
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker